bluebird bio, Inc. (38) | Intellectual Property (6)

Browse by Subcategory

License Agreements (6)

Recent Contracts

Intellectual Property License Agreement, dated as of November 3, 2021, by and between bluebird bio, Inc. and 2seventy bio, Inc (Filed With SEC on November 4, 2021)
Amended and Restated License Agreement by and between the Registrant and Celgene Corporation, dated February 16, 2016 (Filed With SEC on August 9, 2021)
License Agreement by and between the Registrant and Biogen Idec MA Inc., dated August 13, 2014 (Filed With SEC on August 9, 2021)
Exclusive Patent License Agreement by and between the Registrant and the National Institutes of Health, dated August 31, 2015 (Filed With SEC on August 9, 2021)
Second Amended and Restated License Agreement by and between the Registrant and Celgene Corporation and Celgene European Investment Company LLC, dated May 8, 2020 (Filed With SEC on August 5, 2020)
License Agreement, dated December 23, 2015, by and between the Registrant and SIRION Biotech GmbH (Filed With SEC on February 21, 2019)